Skip to main content

ORIGINAL RESEARCH article

Front. Med.

Sec. Nephrology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1489100

This article is part of the Research Topic Impact of oral and gut microbiome on health and diseases View all 14 articles

Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis

Provisionally accepted
Runxi Wang Runxi Wang 1Hongbing Zhou Hongbing Zhou 1Jiaxing Gao Jiaxing Gao 1Xinghua Li Xinghua Li 2Wanfu Bai Wanfu Bai 1Jia Wang Jia Wang 1Yingchun Bai Yingchun Bai 1Liya Fan Liya Fan 1Chang Hong Chang Hong 1*Songli Shi Songli Shi 1*
  • 1 Baotou Medical College, Baotou, China
  • 2 Changzhi People’s Hospital Affiliated to Changzhi Medical College, Changzhi, China, Changzhi, China

The final, formatted version of the article will be published soon.

    The intricate pathogenesis of renal fibrosis necessitates identifying biomarkers at various stages to facilitate targeted therapeutic interventions, which would enhance patient survival rates and significantly improve prognosis. This study aimed to characterize the mechanism of unilateral ureteral obstruction-induced renal fibrosis in rats. We identified 5, 21, and 14 potential gut microbial markers and 19, 23, and 31 potential metabolic markers in the MOD1, MOD2, and MOD4 groups, respectively. Bifidobacterium was identified as a shared microbial marker between the MOD1 and MOD2 groups; Prevotellaceae_NK3B31_group and Bacteroides were identified as shared microbial markers between the MOD2 and MOD4 groups. The pathways of arachidonic acid metabolism and retinol metabolism were found to play a significant role in the modulation of renal fibrosis at 1, 2, and 4 weeks. Notably, the metabolic biomarkers 8,9-EET and 5(S)-HPETE within these pathways emerged as critical determinants influencing renal fibrosis. Our findings demonstrated that the severity of renal fibrosis is associated with dysbiosis of the gut microbiota and alterations in serum metabolites.

    Keywords: Chronic Kidney Disease, renal fibrosis, disease progression, Oxidative Stress, Inflammation, biochemical markers

    Received: 31 Aug 2024; Accepted: 27 Mar 2025.

    Copyright: © 2025 Wang, Zhou, Gao, Li, Bai, Wang, Bai, Fan, Hong and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Chang Hong, Baotou Medical College, Baotou, China
    Songli Shi, Baotou Medical College, Baotou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more